Publications by authors named "Andreas D Hartkopf"

Claim this Profile
O
Overall Survival in Metastatic Breast Cancer Patients: Real-World Data from 1,000 Patients Treated at the NCT Heidelberg between 2014 and 2022.
Laura L Michel, Manuel Feisst, Verena Thewes, Dirk Jäger, Andreas D Hartkopf

Breast Care (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer.
Laura L Michel, Philipp Ziegler, Philipp Kreis, Andreas D Hartkopf, Markus Wallwiener

Eur J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond deficiency: Clinical and molecular predictors of survival in patients with -deficient tubo-ovarian high-grade serous carcinoma.
Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey, Dinuka Ariyaratne, Madawa W Jayawardana, Andreas D Hartkopf

medRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased recurrence risk.
Volkmar Müller, Manuel Hörner, Marc Thill, Maggie Banys-Paluchowski, Sabine Schmatloch, Andreas D Hartkopf

Breast· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: ENABLE-App-Based Digital Capture and Intervention of Patient-Reported Quality of Life, Adverse Events, and Treatment Satisfaction in Breast Cancer: Protocol for a Randomized Controlled Trial.
Thomas M Deutsch, Léa L Volmer, Manuel Feisst, Laura Bodenbeck, Kathrin Hassdenteufel, Andreas D Hartkopf

JMIR Res Protoc· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indirect Treatment Comparison between Ribociclib Combined with Non-Steroidal Aromatase Inhibitors and Ovarian Function Suppression vs. Tamoxifen in Premenopausal Women with Early Breast Cancer.
Diana Lüftner, Maggie Banys-Paluchowski, Andreas D Hartkopf, Manuel Hörner, Wolfgang Janni

Geburtshilfe Frauenheilkd· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer - the SERAPHINA study.
Andreas Schneeweiss, Peter A Fasching, Marc Thill, Marion van Mackelenbergh, Frederik Marme, Andreas D Hartkopf

J Cancer Res Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update Breast Cancer 2024 Part 2 - Patients with Early Stage Breast Cancer.
Wolfgang Janni, Hans-Christian Kolberg, Andreas D Hartkopf, Tanja N Fehm, Manfred Welslau

Geburtshilfe Frauenheilkd· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update Breast Cancer 2024 Part 3 - Patients with Advanced Stage Breast Cancer.
Diana Lüftner, Hans-Christian Kolberg, Andreas D Hartkopf, Tanja N Fehm, Manfred Welslau

Geburtshilfe Frauenheilkd· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ENABLE-App-Based Digital Capture and Intervention of Patient-Reported Quality of Life, Adverse Events, and Treatment Satisfaction in Breast Cancer: Protocol for a Randomized Controlled Trial.
Thomas M Deutsch, Léa L Volmer, Manuel Feisst, Laura Bodenbeck, Kathrin Hassdenteufel, Andreas D Hartkopf

JMIR Res Protoc· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasound-guided breast-conserving surgery compared to conventional breast-conserving surgery.
Bettina Boeer, Jennifer Obermoser, Mario Marx, Birgitt Schönfisch, Marcel Grube, Andreas D Hartkopf

Ultraschall Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and prognosis of patients with primary metastatic disease vs. recurrent HER2-negative, hormone receptor-positive advanced breast cancer.
Christina B Walter, Andreas D Hartkopf, Alexander Hein, Peter A Fasching, Hans-Christian Kolberg

Breast· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2025.
Tjoung-Won Park-Simon, Volkmar Müller, Ute-Susann Albert, Maggie Banys-Paluchowski, Rupert Bartsch, Andreas Daniel Hartkopf

Breast Care (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endometriosis Coinciding with Uterus Didelphys and Renal Agenesis: A Literature Review.
Davut Dayan, Florian Ebner, Wolfgang Janni, Katharina Hancke, Duygu Adiyaman, Andreas Daniel Hartkopf

J Clin Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor DNA in Early and Metastatic Breast Cance-Current Role and What Is Coming Next.
Christian Martin Tegeler, Andreas Daniel Hartkopf, Maggie Banys-Paluchowski, Natalia Krawczyk, Tanja Fehm

Cancers (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutations.
Hannes Armbruster, Tilman Schotte, Isabell Götting, Mathis Overkamp, Massimo Granai, Andreas D Hartkopf

Virchows Arch· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical activity levels are positively related to progression-free survival and reduced adverse events in advanced ER breast cancer.
Philipp Zimmer, Tobias Esser, Diana Lueftner, Florian Schuetz, Freerk T Baumann, Andreas D Hartkopf

BMC Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype.
Philipp Ziegler, Andreas D Hartkopf, Markus Wallwiener, Lothar Häberle, Hans-Christian Kolberg

BMC Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast Cancer and Mental Health: Incidence and Influencing Factors-A Claims Data Analysis from Germany.
Alexandra von Au, Dominik Dannehl, Tjeerd Maarten Hein Dijkstra, Raphael Gutsfeld, Anna Sophie Scholz, Andreas Daniel Hartkopf

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Obstetric Outcomes after Breast Cancer Diagnosis: An Observational Database Study in Germany.
Anna Sophie Scholz, Alexandra von Au, Raphael Gutsfeld, Tjeerd Maarten Hein Dijkstra, Dominik Dannehl, Andreas Daniel Hartkopf

Cancers (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer.
Peter A Fasching, Chunling Hu, Steven N Hart, Matthias Ruebner, Eric C Polley, Andreas D Hartkopf

NPJ Breast Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update Breast Cancer 2024 Part 1 - Expert Opinion on Advanced Breast Cancer.
Rachel Würstlein, Hans-Christian Kolberg, Andreas D Hartkopf, Tanja N Fehm, Manfred Welslau

Geburtshilfe Frauenheilkd· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024.
Tjoung-Won Park-Simon, Volkmar Müller, Ute-Susann Albert, Maggie Banys Paluchowski, Ingo Bauerfeind, Andreas Daniel Hartkopf

Breast Care (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK4/6 Inhibition - Therapy Sequences and the Quest to Find the Best Biomarkers - an Overview of Current Programs.
Andreas Schneeweiss, Sara Y Brucker, Hanna Huebner, Lea L Volmer, Carolin C Hack, Andreas D Hartkopf

Geburtshilfe Frauenheilkd· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the HER2 Status of the Primary Tumor to That of Disseminated Tumor Cells in Early Breast Cancer.
Léa Louise Volmer, Dominik Dannehl, Sabine Matovina, Florin-Andrei Taran, Christina Barbara Walter, Andreas Daniel Hartkopf

Int J Mol Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis